Regal Investment Advisors LLC Astrazeneca PLC Transaction History

Regal Investment Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $191,587 - $229,995	-3,233 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $44,854 - $54,031	-805 Reduced 19.94%	3,233 $214,000
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $9,993 - $11,808	185 Added 4.8%	4,038 $235,000
Q3 2021 Nov 05, 2021	SELL	$55.56 - $60.79 $6,111 - $6,686	-110 Reduced 2.78%	3,853 $231,000
Q2 2021 Aug 09, 2021	BUY	$48.42 - $60.18 $191,888 - $238,493	3,963 New	3,963 $237,000
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $197,223 - $227,668	-4,182 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $202,910 - $242,639	4,182 New	4,182 $209,000

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regal Investment Advisors LLC with notifications on news.